Alentis Therapeutics

Q: What is Alentis Therapeutics's company size?

Alentis therapeutics has 51 - 200 people working.

Pharmaceutical Manufacturing

Specialities :

Claudin-1

Cldn1

Claudin

Oncology

Cancer

+17

Revenue

11M - 100M

Total Funding

Size

51 - 200

About Us

Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of anti-cancer therapies designed to reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is highly promising for drug development as many cancers use the TME to build barriers that shield against immune system attacks. Alentis lead oncology asset, ALE.C04, is the first potential treatment to target CLDN1 in so...

Contact Information

Allschwil , Basel-Landschaft , Switzerland

last@alentis.ch

alentis.ch

Alentis Therapeutics Org Chart

Alentis Therapeutics

(Pharmaceuticals)

51 - 200

Roberto Iacone

Chief Executive Officer

View Email

View Contact

View Email

View Contact

Employees

Total Employees:
37

Top Contacts:
3

C-Level 0	VP - Level1
Director-	Manager2
Others35

Employees Working At Alentis Therapeutics

Luigi Manenti

CMO

Corentin Herbert

Director Translational Research

Alexandru Papoiu

Medical Director

Silvia Cavadini

Research Associate Fibrosis

Ruth U

Research Associate

Alentis Therapeutics Email Formats

Structure	Email Format
<first>.<last>@	John.Smith@alentis.ch

Buyer Intent

Pain Points	Locations	Technologies
Digital Transformation	Allschwil, Basel-Country, Switzerland	financial, ec, share
Networking	Allschwil, Basel-Country, Switzerland	financial, ec, share
Project Management	Allschwil, Basel-Country, Switzerland	financial, ec, share

Trigger

Tech Stack Used By Alentis Therapeutics

List of technologies used by Alentis Therapeutics

Financial

Languages Used By Alentis Therapeutics

OS Used By Alentis Therapeutics

Jobs at Alentis Therapeutics

Hiring 2024-09-25 10:59:23

Head Finance

Allschwil, Basel-Country, Switzerland

Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis...

Frequently Asked Questions About Alentis Therapeutics

What does Alentis therapeutics do?+

What are Alentis therapeutics's specialties? +

Claudin-1,cldn1,claudin,oncology,cancer,kidney fibrosis,rare diseases,nephrology,lung fibrosis,liver fibrosis,ale.c04,ale.f02,drug development,drug discovery,pulmonology,hepatology,fibrosis,antibody-drug conjugates,adc,hnscc,idiopathic pulmonary fibrosis,and anca-associated vasculitis